Back to Search
Start Over
Percutaneous Neuromodulation for Atrial Fibrillation.
- Source :
-
Cardiac electrophysiology clinics [Card Electrophysiol Clin] 2024 Sep; Vol. 16 (3), pp. 281-296. Date of Electronic Publication: 2023 Oct 05. - Publication Year :
- 2024
-
Abstract
- Percutaneous neuromodulation is emerging as a promising therapeutic approach for atrial fibrillation (AF). This article explores techniques such as ganglionated plexi (GP) ablation, and vagus nerve stimulation, pinpointing their potential in modulating AF triggers and maintenance. Noninvasive methods, such as transcutaneous low-level tragus stimulation, offer innovative treatment pathways, with early trials indicating a significant reduction in AF burden. GP ablation may address autonomic triggers, and the potential for GP ablation in neuromodulation is discussed. The article stresses the necessity for more rigorous clinical trials to validate the safety, reproducibility, and efficacy of these neuromodulation techniques in AF treatment.<br />Competing Interests: Disclosure Nil.<br /> (Crown Copyright © 2023. Published by Elsevier Inc. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1877-9190
- Volume :
- 16
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Cardiac electrophysiology clinics
- Publication Type :
- Academic Journal
- Accession number :
- 39084721
- Full Text :
- https://doi.org/10.1016/j.ccep.2023.09.001